Transcend Capital Advisors’s Akoya BioSciences AKYA Stock Holding History

Transcend Capital Advisors’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-27,602	Closed	-$35.9K	–	695
2025 Q2	$35.9K	Buy	27,602 +2	+0%	+$2	﹤0.01%	614
2025 Q1	$38.4K	Hold	27,600	–	–	﹤0.01%	600
2024 Q4	$63.2K	Hold	27,600	–	–	﹤0.01%	565
2024 Q3	$75.1K	Buy	+27,600	New	+$67.4K	0.01%	610

Transcend Capital Advisors's AKYA Position: Q3 2025 in Review

Transcend Capital Advisors sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 27,602 shares — an estimated $35.9K sold.

Transcend Capital Advisors first reported a position in AKYA in Q3 2024 and held it in 4 quarters. The position peaked at $75.1K in Q3 2024. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.

Transcend Capital Advisors reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
Transcend Capital Advisors sold 27,602 Akoya BioSciences shares in Q3 2025, an estimated $35.9K.
Transcend Capital Advisors first reported a position in Akoya BioSciences in Q3 2024 and held it in 4 quarters.
Transcend Capital Advisors's Akoya BioSciences position peaked at $75.1K in Q3 2024.
0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.

Based on Transcend Capital Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.